MedPath

Placement of a double-J catheter transurethral via the urinary bladder versus transcutaneous via the kidney in patients with extrinsic obstruction of the ureter.

Conditions
Extrinsieke ureter obstructieExtrinsic ureter obstruction
Registration Number
NL-OMON25446
Lead Sponsor
Dr. H. van OverhagenHaga ZiekienhuisLeyweg 2752545 CH Den Haag070-2100000h.voverhagen@hagaziekenhuis.nl
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
214
Inclusion Criteria

• Legally capable and written informed consent
• 18 years or older
• A CT or MRI diagnosis of extrinsic ureter obstruction by visible or non-visible mass surrounding the urinary tract
• Possible dorsal percutaneous approach to kidney
• Possible transvesical approach
• Possible treatment by an urologist and intervention radiologist with sufficient experience
• Patient is willing and able to comply with the specified follow-up evaluation

Exclusion Criteria

• Active infection, defined as temperature >38,0 °C
• Macroscopic haematuria
• INR > 2,0
• Thrombocytes < 50 109/l
• Ileal conduit urinary diversion
• Kidney transplantation
• Horseshoe kidney
• Known allergy to contrast media
• Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Immediate technical success rate
Secondary Outcome Measures
NameTimeMethod
• To compare VAS scores after retrograde and antegrade stent insertion in patients with extrinsic urinary tract obstruction.<br>• To compare the complications after retrograde and antegrade stent insertion in patients with extrinsic urinary tract obstruction.<br>• To compare technical success rates at 30 days after retrograde and antegrade stent insertion in patients with extrinsic urinary tract obstruction.<br>• To compare scores on EQ5D questionnaire at 30 days after retrograde and antegrade stent insertion in patients with extrinsic urinary tract obstruction.<br>• To assess possible predictive factors for immediate technical success.<br>• To assess possible predictive factors for technical success at 30 days.<br>• To assess possible predictive factors for the evolvement of major and minor complications.<br>• To assess possible predictive factors for the outcome on the EQ5D questionnaire.<br>
© Copyright 2025. All Rights Reserved by MedPath